-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Abbott Laboratories, Raises Price Target to $134

Benzinga·07/17/2026 10:13:32
语音播报
BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $131 to $134.